Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia

被引：1
|
作者：
Csizmar, Clifford M. [1 ]
Saliba, Antoine N. [2 ]
Litzow, Mark R. [2 ]
Gangat, Naseema [2 ]
Al-Kali, Aref [2 ]
Foran, James M. [3 ]
Hogan, William J. [2 ]
Palmer, Jeanne M. [4 ]
Mangaonkar, Abhishek A. [2 ]
McCullough, Kirsten [2 ]
Tefferi, Ayalew [2 ]
Alkhateeb, Hassan B. [2 ]
Patnaik, Mrinal M. M. [2 ]
机构：
[1] Mayo Clin, Dept Med, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin, Div Hematol Oncol & Blood & Marrow Transplanat &, Jacksonville, FL 32224 USA
[4] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165470
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12238 / 12240
页数：3
相关论文
共 50 条
  • [1] Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia
    Saliba, Antoine N.
    Litzow, Mark R.
    Gangat, Naseema
    Al-Kali, Aref
    Foran, James M.
    Hogan, William J.
    Palmer, Jeanne M.
    Mangaonkar, Abhishek A.
    Tefferi, Ayalew
    Patnaik, Mrinal M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (11) : E433 - E436
  • [2] Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia
    Danielle Hammond
    Guillermo Montalban-Bravo
    Current Hematologic Malignancy Reports, 2021, 16 : 405 - 417
  • [3] Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia
    Hammond, Danielle
    Montalban-Bravo, Guillermo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 405 - 417
  • [4] Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series
    Garcia-Horton, Alejandro
    Maze, Dawn
    McNamara, Caroline J.
    Sibai, Hassan
    Gupta, Vikas
    Murphy, Tracy
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1525 - 1527
  • [5] Activity of venetoclax-based therapy in chronic myelomonocytic leukemia
    Guillermo Montalban-Bravo
    Danielle Hammond
    Courtney D. DiNardo
    Marina Konopleva
    Gautam Borthakur
    Nicholas J. Short
    Jorge Ramos-Perez
    Veronica Guerra
    Rashmi Kanagal-Shamanna
    Kiran Naqvi
    Koji Sasaki
    Elias Jabbour
    Naveen Pemmaraju
    Tapan M. Kadia
    Farhad Ravandi
    Naval Daver
    Zeev Estrov
    Sherry Pierce
    Hagop Kantarjian
    Guillermo Garcia-Manero
    Leukemia, 2021, 35 : 1494 - 1499
  • [6] Activity of venetoclax-based therapy in chronic myelomonocytic leukemia
    Montalban-Bravo, Guillermo
    Hammond, Danielle
    DiNardo, Courtney D.
    Konopleva, Marina
    Borthakur, Gautam
    Short, Nicholas J.
    Ramos-Perez, Jorge
    Guerra, Veronica
    Kanagal-Shamanna, Rashmi
    Naqvi, Kiran
    Sasaki, Koji
    Jabbour, Elias
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Estrov, Zeev
    Pierce, Sherry
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    LEUKEMIA, 2021, 35 (05) : 1494 - 1499
  • [7] Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia
    Molina, John C.
    Asare, Julie M.
    Tuschong, Laura
    West, Robert R.
    Calvo, Katherine R.
    Persky, Rebecca
    Boyce, Alison M.
    Hammoud, Dima A.
    Holland, Steven M.
    Hickstein, Dennis
    Shah, Nirali N.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (03)
  • [8] Blast-phase chronic myelomonocytic leukemia: more than just semantics
    Mrinal M. Patnaik
    Ayalew Tefferi
    Guillermo Garcia-Manero
    Leukemia, 2018, 32 : 2093 - 2094
  • [9] Blast-phase chronic myelomonocytic leukemia: more than just semantics
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    Garcia-Manero, Guillermo
    LEUKEMIA, 2018, 32 (09) : 2093 - 2094
  • [10] Integrative Analysis of Blast Phase Chronic Myelomonocytic Leukemia Reveals Distinct Transformation Phenotypes Predictive of Drug Response
    Gurashi, Kristian
    Wang, Yu-Hung
    Somervaille, Tim C. P.
    Batta, Kiran
    Wiseman, Daniel H.
    BLOOD, 2022, 140
12345